Roivant Sciences Ltd.
ROIV
Classement en actions
#978
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Prix de l'action
$33.73
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$24.37B
Changement (1 jour)
-2.28%
Changement (1 an)
90.15%
Pays
GB
Échange Roivant Sciences Ltd. (ROIV)
Catégorie
Healthcare
Historique du rendement du dividende pour Roivant Sciences Ltd. (ROIV)
Le rendement du dividende (TTM) de Roivant Sciences Ltd. (symbole boursier : ROIV) au 2024-03-31 est : 0.07%
Rendement moyen du dividende sur les 5 dernières années : 0.01%
Rendement moyen du dividende sur les 5 dernières années : 0.01%
Historique du rendement du dividende de Roivant Sciences Ltd. (ROIV) de 2020 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | 0.07% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
